Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. MacKinnon, S. Farnworth, M. Gibbons, T. Sethi (Edinburgh, United Kingdom). Late Breaking Abstract: Galectin-3 a key regulator in the development of lung fibrosis. Eur Respir J 2010; 36: Suppl. 54, 207

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD. Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - Calpain regulates epithelial-mesenchymal transition and its correlation with Akt signaling in pulmonary fibrosis. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung Year: 2016 Is TGFb a central mediator in the development of pulmonary fibrosis? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Late Breaking Abstract - Investigation of the epithelial-mesenchymal paracrine interactions in lung tissue repair and fibrosis. Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Late Breaking Abstract: Expression of S100A4 in COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Late Breaking Abstract - Assessment of a ciliary transport protein in airway cells reveals novel pattern in cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis Source: International Congress 2018 – Biomarkers of COPD Year: 2018 The role of miR-21 and miR-34a in the fibrotic process of the lung Source: International Congress 2016 – IPF pathogenesis Year: 2016